Rimmyrah 10 mg/ml solution for injection ${equilateral_black_triangle}$

Active Ingredient:

ranibizumab

Company:

Orion Pharma (UK) Limited See contact details

ATC code:

S01LA04

About Medicine

${medical_services}$

Prescription only medicine

My Account Area

${arrow_down}$

Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs Audio/Video

${arrow_left}$

${arrow_right}$

Rimmyrah nAMD educational materials - Audio Version
Audio version of Rimmyrah nAMD educational materials - Important safety information for patients treated with: RIMMYRAH (ranibizumab) in wet (neovascular) age related macular degeneration (nAMD)

Rimmyrah CNV educational materials - Audio Version
Audio version of Rimmyrah CNV educational materials - Important safety information for patients treated with: RIMMYRAH (ranibizumab) with visual impairment due to choroidal neovascularisation (CNV) secondary to pathological myopia

Rimmyrah PDR/DMO educational materials - Audio Version
Audio version of Rimmyrah DMO educational materials - Important safety information for patients treated with: RIMMYRAH (ranibizumab) with proliferative diabetic retinopathy (PDR) and/or visual impairment due to diabetic macular oedema (DMO)

Rimmyrah RVO educational materials - Audio Version
Audio version of Rimmyrah RVO educational materials - Important safety information for patients treated with: RIMMYRAH (ranibizumab) with visual impairment due to retinal vein occlusion (RVO)